Acquisitions /mergers/joint-ventures   NeoGenomics (Fort Myers, FL, USA) an oncology genomics company, acquires GE Clarient Diagnostic Services in cash in a deal worth $300 million. The two companies have also agreed to collaborate on a precision oncology bioinformatics initiative aimed at integrating genomics and imaging data. "Our vision is to become America's premier cancer testing laboratory, […]

Acquisitions /mergers/joint-ventures   Roche acquires Adheron Therapeutics (San Francisco, CA, USA) for up to $580 million. Adheron has developed a technology which disrupts immune cell adhesion through a protein called Cadherin-11 with a current lead SDP051 which has completed Phase 1 studies. Under the terms of the agreement Roche will pay an upfront of $105 million […]

The Nobel Prize in Physiology or Medicine 2015 has been awarded to William Campbell and  Satoshi Omura for their discoveries concerning a novel therapy (avermectin) against infections caused by roundworm parasites" and to Youyou Tu "for her discoveries concerning a novel therapy against Malaria". To the best of our knowledge this is the first time the price is awarded […]

Innovation Days, Paris, October 5-6,2015   Download the presentation given by Jean-Claude Muller  at Innovation Days: MAJOR DEALS & TRANSACTIONS FOR PHARMA, BIOTECH & HEALTHCARE   If you don't want to miss next Pharma-Biotech Deal Transaction, Register to our Biopharmaceutical news published every week.   

Acquisitions /mergers/joint-ventures   Teva acquires Mexico-based generic company Representaciones e Investiagaciones Medicas known as Rimsa for $2.3 billion and beefs up in emerging markets. The buyout is expected to close early next year.     Business   MedImmune licenses 3M Drug Delivery Systems’ MEDI9197, a next generation “toll-like” receptor agonist as a head and neck cancer […]

• Biopharmaceutical News • Biofit, 2015 –TECHNOMARKET & PRESENTING TECHNOLOGIES SESSIONS: Immunology & Oncology   • A way forward for pricing new pharmaceuticals  • Innovation Days, Paris, 2015 : Major Deal Transactions for Pharma, Biotech and Healthcare  • The Breakthrough of Immunotherapy • 2015 A turning point for the Bio-Pharma Insdustry • Reshaping the European pharmaceutical industry • Bio-Europe Spring 2014 • Investigating the […]